Tommi Tallheden

Title: Tommi Tallheden: Innovator in Stem Cell Technology

Introduction

Tommi Tallheden is a prominent inventor based in Gothenburg, Sweden. He has made significant contributions to the field of stem cell research, particularly in the efficient transfer and propagation of human blastocyst-derived stem cells.

Latest Patents

Tallheden holds a patent for a method that facilitates the efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system. This innovative method allows for the long-term propagation of hBS cells under feeder-free conditions. The patent outlines a process that includes transferring the cells through mechanical treatment, culturing them in a suitable growth medium, and passaging the cell line every 3-10 days using enzymatic and/or mechanical treatment. This invention has important applications in medicine, particularly in myocardial regeneration and toxicity testing.

Career Highlights

Tommi Tallheden is associated with Cellartis AB, a company that focuses on stem cell technology and regenerative medicine. His work has been instrumental in advancing the understanding and application of stem cells in various medical fields.

Collaborations

Tallheden has collaborated with notable colleagues, including Eva Karin Kilmare and Sven Enerbäck, contributing to the collective expertise in stem cell research and applications.

Conclusion

Tommi Tallheden's innovative work in stem cell technology exemplifies the potential of scientific research to impact medical advancements. His contributions continue to pave the way for future developments in regenerative medicine.